Supriya Lifescience (NSE:SUPRIYA) Construction In Progress: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUPRIYA Supriya Lifescience Ltd NSE:SUPRIYA
83 GF Score
Price ₹811.70
GF Value ₹860.01
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Supriya Lifescience Construction In Progress?

Supriya Lifescience NSE:SUPRIYA +3.03% 83 Construction In Progress is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:SUPRIYA with a GF Score™ of 83/100 and a GF Value™ of ₹860.01 (Fairly Valued). The stock has 3 warning signs investors should review.

Supriya Lifescience's quarterly construction in progress increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹355 Mil) but then declined from Mar. 2026 (₹355 Mil) to Jun. 2026 (₹0 Mil).

Supriya Lifescience's annual construction in progress increased from Mar. 2024 (₹1,488 Mil) to Mar. 2025 (₹1,579 Mil) but then declined from Mar. 2025 (₹1,579 Mil) to Mar. 2026 (₹355 Mil).

Supriya Lifescience Construction In Progress Historical Data

* Premium members only.

The historical data trend for Supriya Lifescience's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supriya Lifescience Construction In Progress Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial 434.09 676.28 1,488.25 1,578.59 355.48

Supriya Lifescience Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,724.95 0.00 355.48 0.00
NSE:SUPRIYA
83GF Score
Supriya Lifescience Ltd NSE:SUPRIYA
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supriya Lifescience Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹0 Mil mean?
Supriya Lifescience (NSE:SUPRIYA) has a Construction In Progress of ₹0 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Supriya Lifescience and its competitors.
Is Supriya Lifescience's Construction In Progress too high?
Supriya Lifescience's current Construction In Progress is ₹0 Mil. Overall, Supriya Lifescience has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Supriya Lifescience's Construction In Progress compare to VRTX and REGN?
Supriya Lifescience's Construction In Progress of ₹0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Supriya Lifescience and its competitors. Supriya Lifescience's current Construction In Progress is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supriya Lifescience stock overvalued right now?
Based on GuruFocus' analysis, Supriya Lifescience (NSE:SUPRIYA) is currently considered Fairly Valued. The stock's GF Value™ is ₹860.01, compared to a current price of ₹811.70 — trading 5.6% below its estimated fair value. The current Construction In Progress is ₹0 Mil. Supriya Lifescience's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Supriya Lifescience (NSE:SUPRIYA), the current Construction In Progress is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supriya Lifescience (NSE:SUPRIYA) Overvalued in 2026?

Based on GuruFocus' analysis, Supriya Lifescience stock appears to be undervalued. The current stock price of ₹811.70 is trading 5.6% below its estimated GF Value™ of ₹860.01. GuruFocus considers Supriya Lifescience to be Fairly Valued.

Key valuation signals for NSE:SUPRIYA:

  • Construction In Progress: ₹0 Mil
  • GF Value™: ₹860.01 vs. price of ₹811.70 (5.6% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the NSE:SUPRIYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supriya Lifescience Business Description

Other Exchanges 543434:India
Address Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
83GF Score

Get the complete analysis for NSE:SUPRIYA

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹811.70
Price
₹860.01
GF Value